advanced or metastatic breast cancer
Showing 1 - 10 of 10
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- Milademetan
- Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
-
Paris, FranceInstitut Curie
Jun 27, 2023
Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer Trial in Worldwide (AZD5363 when combined with
Completed
- Advanced or Metastatic Breast Cancer
- ER+ve Advanced or Metastatic Breast Cancer
- AZD5363 when combined with weekly paclitaxel.
- +2 more
-
Plovdiv, Bulgaria
- +40 more
Dec 23, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Advanced or Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Paclitaxel)
Recruiting
- Advanced or Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Scottsdale, Arizona
- +343 more
Jul 22, 2022
Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- AND019 PO QD
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 19, 2022
Advanced or Metastatic Breast Cancer Trial in Worldwide (MEN1611, Trastuzumab, Fulvestrant)
Active, not recruiting
- Advanced or Metastatic Breast Cancer
- MEN1611
- +2 more
-
Fort Lauderdale, Florida
- +26 more
Feb 14, 2022
Advanced or Metastatic Breast Cancer Trial in Spain, United States (LEE011, Buparlisib, Letrozole)
Completed
- Advanced or Metastatic Breast Cancer
- LEE011
- +2 more
-
Los Angeles, California
- +5 more
Dec 16, 2020
Advanced or Metastatic Solid Tumors, Advanced or Metastatic Breast Cancer Trial in Salt Lake City (Azacitidine (Vidaza),
Completed
- Advanced or Metastatic Solid Tumors
- Advanced or Metastatic Breast Cancer
- Azacitidine (Vidaza)
- Nab-paclitaxel (Abraxane)
-
Salt Lake City, UtahUniversity of Utah Huntsman Cancer Institute
Jun 27, 2017